{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T07:46:49Z","timestamp":1791704809272,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2025MS1363"],"award-info":[{"award-number":["ZR2025MS1363"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.tranon.2026.103050","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:12:56Z","timestamp":1790010776000},"page":"103050","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["IL-32 drives PR3-dependent NET formation to promote portal vein tumor thrombosis and radioresistance in HCC"],"prefix":"10.1016","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7713-9705","authenticated-orcid":false,"given":"Liming","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangjun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengcheng","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohai","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiming","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tranon.2026.103050_bib0001","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.tranon.2026.103050_bib0002","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"1","key":"10.1016\/j.tranon.2026.103050_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3350\/cmh.2023.0125","article-title":"Recent advances in the management of hepatocellular carcinoma","volume":"30","author":"Sankar","year":"2024","journal-title":"Clin. Mol. Hepatol."},{"issue":"1","key":"10.1016\/j.tranon.2026.103050_bib0004","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/JLB.3MR0620-550R","article-title":"Molecular interactions and functions of IL-32","volume":"109","author":"Aass","year":"2021","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.tranon.2026.103050_bib0005","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.pharmthera.2017.02.025","article-title":"Interleukin 32, inflammation and cancer","volume":"174","author":"Hong","year":"2017","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.tranon.2026.103050_bib0006","doi-asserted-by":"crossref","DOI":"10.3390\/ph17040531","article-title":"The role of \u03b1-Enolase on the production of interleukin (IL)-32 in con a-mediated inflammation and rheumatoid arthritis (RA)","volume":"17","author":"Jo","year":"2024","journal-title":"Pharmaceuticals. (Basel)"},{"issue":"3","key":"10.1016\/j.tranon.2026.103050_bib0007","doi-asserted-by":"crossref","DOI":"10.4110\/in.2018.18.e20","article-title":"Role of IL-32 gamma on bone metabolism in autoimmune arthritis","volume":"18","author":"Kwon","year":"2018","journal-title":"Immune Netw."},{"key":"10.1016\/j.tranon.2026.103050_bib0008","article-title":"IL-32 and IL-34 in hepatocellular carcinoma","volume":"9","author":"Si","year":"2022","journal-title":"Front. Med. (Lausanne)"},{"issue":"17","key":"10.1016\/j.tranon.2026.103050_bib0009","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713222","article-title":"Saturated fat-mediated upregulation of IL-32 and CCL20 in hepatocytes contributes to higher expression of these fibrosis-driving molecules in MASLD","volume":"24","author":"Schilcher","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.tranon.2026.103050_bib0010","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1073\/pnas.0511206103","article-title":"Proteinase 3 is an IL-32 binding protein","volume":"103","author":"Novick","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U S. A"},{"issue":"7","key":"10.1016\/j.tranon.2026.103050_bib0011","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nrc.2016.52","article-title":"Neutrophils in cancer: neutral no more","volume":"16","author":"Coffelt","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.tranon.2026.103050_bib0012","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nri.2017.105","article-title":"Neutrophil extracellular traps in immunity and disease","volume":"18","author":"Papayannopoulos","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.tranon.2026.103050_bib0013","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.semcancer.2021.07.011","article-title":"Neutrophil extracellular traps in cancer","volume":"79","author":"Cristinziano","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"8","key":"10.1016\/j.tranon.2026.103050_bib0014","doi-asserted-by":"crossref","DOI":"10.3390\/biom9080365","article-title":"Neutrophil Extracellular Trap Formation: Physiology, Pathology, and Pharmacology","volume":"9","author":"Ravindran","year":"2019","journal-title":"Biomolecules."},{"issue":"1","key":"10.1016\/j.tranon.2026.103050_bib0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13045-019-0836-0","article-title":"Increased neutrophil extracellular traps promote metastasis potential of hepatocellular carcinoma via provoking tumorous inflammatory response","volume":"13","author":"Yang","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.tranon.2026.103050_bib0016","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/cac2.12388","article-title":"Elevated neutrophil extracellular traps by HBV-mediated S100A9-TLR4\/RAGE-ROS cascade facilitate the growth and metastasis of hepatocellular carcinoma","volume":"43","author":"Zhan","year":"2023","journal-title":"Cancer Commun. (Lond)"},{"issue":"8","key":"10.1016\/j.tranon.2026.103050_bib0017","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/ATVBAHA.111.242859","article-title":"Neutrophil extracellular trap (NET) impact on deep vein thrombosis","volume":"32","author":"Fuchs","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.tranon.2026.103050_bib0018","doi-asserted-by":"crossref","DOI":"10.12771\/emj.2025.e4","article-title":"Management strategies for advanced hepatocellular carcinoma with portal vein tumor thrombosis","volume":"48","author":"Park","year":"2025","journal-title":"Ewha Med J"},{"issue":"12","key":"10.1016\/j.tranon.2026.103050_bib0019","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.3748\/wjg.v21.i12.3462","article-title":"Management of hepatocellular carcinoma with portal vein thrombosis","volume":"21","author":"Quirk","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.tranon.2026.103050_bib0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12943-024-02049-0","article-title":"Tumor cell-intrinsic MELK enhanced CCL2-dependent immunosuppression to exacerbate hepatocarcinogenesis and confer resistance of HCC to radiotherapy","volume":"23","author":"Tang","year":"2024","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2026.103050_bib0021","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s13046-020-01734-4","article-title":"UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation","volume":"39","author":"Sun","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.tranon.2026.103050_bib0022","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.jhep.2022.01.009","article-title":"COMMD10 inhibits HIF1\u03b1\/CP loop to enhance ferroptosis and radiosensitivity by disrupting Cu-Fe balance in hepatocellular carcinoma","volume":"76","author":"Yang","year":"2022","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.tranon.2026.103050_bib0023","first-page":"1155","article-title":"Overexpression of interleukin-32\u03b1 promotes invasion by modulating VEGF in hepatocellular carcinoma","volume":"39","author":"Zhao","year":"2018","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.tranon.2026.103050_bib0024","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13045-021-01187-y","article-title":"Neutrophils in cancer carcinogenesis and metastasis","volume":"14","author":"Xiong","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2026.103050_bib0025","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1038\/s41467-021-23086-z","article-title":"Role of neutrophil extracellular traps in radiation resistance of invasive bladder cancer","volume":"12","author":"Shinde-Jadhav","year":"2021","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.tranon.2026.103050_bib0026","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ccell.2024.01.007","article-title":"Precision treatment in advanced hepatocellular carcinoma","volume":"42","author":"Yang","year":"2024","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.tranon.2026.103050_bib0027","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s41467-019-09160-7","article-title":"Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia","volume":"10","author":"Perdomo","year":"2019","journal-title":"Nat. Commun."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326003864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326003864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T07:28:28Z","timestamp":1791703708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326003864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":27,"alternative-id":["S1936523326003864"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103050","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-32 drives PR3-dependent NET formation to promote portal vein tumor thrombosis and radioresistance in HCC","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103050"}}